SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 416 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.97 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,547,000 | +107.1% | 13,996 | +40.5% | 0.05% | +92.9% |
| Q2 2022 | $747,000 | +55.3% | 9,962 | +61.9% | 0.03% | +75.0% |
| Q1 2022 | $481,000 | +40.6% | 6,154 | +62.2% | 0.02% | +33.3% |
| Q4 2021 | $342,000 | -50.7% | 3,795 | -49.4% | 0.01% | -47.8% |
| Q3 2021 | $694,000 | -72.1% | 7,503 | -57.6% | 0.02% | -91.3% |
| Q3 2020 | $2,485,000 | +495.9% | 17,696 | +580.1% | 0.26% | +473.9% |
| Q2 2020 | $417,000 | +134.3% | 2,602 | +10.1% | 0.05% | -9.8% |
| Q3 2019 | $178,000 | +17700.0% | 2,363 | +26155.6% | 0.05% | – |
| Q4 2018 | $1,000 | -66.7% | 9 | -88.5% | 0.00% | -100.0% |
| Q2 2017 | $3,000 | – | 78 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 1,010,330 | $122,472,203 | 13.56% |
| Finepoint Capital LP | 145,357 | $17,620,176 | 8.78% |
| Avoro Capital Advisors LLC | 4,025,000 | $487,910,500 | 7.61% |
| Saturn V Capital Management LP | 118,401 | $14,352,569 | 6.01% |
| Ghost Tree Capital, LLC | 150,000 | $18,183,000 | 5.98% |
| Ikarian Capital, LLC | 3,673 | $44,524,106 | 5.36% |
| ACUTA CAPITAL PARTNERS, LLC | 550 | $7,580,650 | 5.08% |
| Eagle Health Investments LP | 174,212 | $21,117,979 | 4.65% |
| Boxer Capital, LLC | 600,000 | $72,732,000 | 3.87% |
| GREAT POINT PARTNERS LLC | 165,200 | $20,025,544 | 3.65% |